Skip to content

Penumbra PEN Intangibles (Net)

Intangibles (Net) at other companies

Medtronic logo
MedtronicMDT
$10.15B-13.0%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's intangibles (net)?
Penumbra (PEN) reported intangibles (net) of $5.95M in Q1 2026.
How has Penumbra's intangibles (net) changed year-over-year?
Penumbra's intangibles (net) decreased by 8.1% year-over-year, from $6.47M to $5.95M.
What is the long-term trend for Penumbra's intangibles (net)?
Over 5 years (2020 to 2025), Penumbra's intangibles (net) has grown at a -10.3% compound annual growth rate (CAGR), from $10.64M to $6.19M.
What does intangibles (net) mean?
The value of non-physical assets like patents and intellectual property, minus amortization.
How do you interpret intangibles (net)?
Higher values suggest a strong portfolio of intellectual property, though high amortization can impact reported earnings.
How does intangibles (net) compare across companies?
High for innovation-driven sectors; peers are compared based on the strength and remaining life of their patent portfolios.